Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-03
DOI
10.3389/fimmu.2019.00694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
- (2017) Mohammad Alhadj Ali et al. Science Translational Medicine
- Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
- (2017) Alix K. Berglund et al. Stem Cell Research & Therapy
- Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid
- (2017) Madeleine C. Killer et al. Stem Cell Research & Therapy
- The Future of Immunotherapy: A 20-Year Perspective
- (2017) David C. Wraith Frontiers in Immunology
- Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
- (2017) Jessica S. Suwandi et al. Frontiers in Immunology
- Mesenchymal stem cells moderate immune response of type 1 diabetes
- (2016) Junbi Xv et al. CELL AND TISSUE RESEARCH
- Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
- (2016) Mehdi Najar et al. CYTOTHERAPY
- Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
- (2016) I Aldoss et al. LEUKEMIA
- Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation
- (2016) Austin Nuschke et al. Stem Cell Research & Therapy
- Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
- (2015) Per-Ola Carlsson et al. Current Diabetes Reports
- Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
- (2015) Enrica Favaro et al. DIABETOLOGIA
- Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34+Transplants
- (2015) Mark van der Garde et al. STEM CELLS AND DEVELOPMENT
- Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation
- (2014) Jessica Cuerquis et al. CYTOTHERAPY
- Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
- (2014) Per-Ola Carlsson et al. DIABETES
- Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes
- (2014) Enrica Favaro et al. DIABETOLOGIA
- Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation
- (2014) Kisha Nandini Sivanathan et al. Stem Cell Reviews and Reports
- Uptake and delivery of antigens by mesenchymal stromal cells
- (2013) Luis Ignacio Sánchez-Abarca et al. CYTOTHERAPY
- Metabolic Pathways in Immune Cell Activation and Quiescence
- (2013) Erika L. Pearce et al. IMMUNITY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- The Antidiabetic Effect of Mesenchymal Stem Cells Is Unrelated to Their Transdifferentiation Potential But to Their Capability to Restore Th1/Th2 Balance and to Modify the Pancreatic Microenvironment
- (2012) Fernando Ezquer et al. STEM CELLS
- Assessing mitochondrial dysfunction in cells
- (2011) Martin D. Brand et al. BIOCHEMICAL JOURNAL
- Human Mesenchymal Stem Cells Modulate Cellular Immune Response to Islet Antigen Glutamic Acid Decarboxylase in Type 1 Diabetes
- (2010) Maria M. Zanone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially
- (2010) S. Jyothi Prasanna et al. PLoS One
- Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
- (2009) M. Francois et al. BLOOD
- Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells
- (2009) A. M. Madec et al. DIABETOLOGIA
- A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
- (2008) Huiming Sheng et al. CELL RESEARCH
- MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge
- (2008) Wing Keung Chan et al. EXPERIMENTAL HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More